江苏菲沃泰纳米科技股份有限公司 2025 年股票期权激励计划实施考核管理办法 江苏菲沃泰纳米科技股份有限公司（以下简称"菲沃泰"或"公司"）为了进一 步建立、健全公司长效激励机制，吸引和留住优秀人才，充分调动公司核心团队 的积极性，有效地将股东利益、公司利益和核心团队个人利益结合在一起，使各 方共同关注和推动公司的长远发展，确保公司发展战略和经营目标的实现，在充 分保障股东利益的前提下，按照激励与约束对等的原则，制定了《江苏菲沃泰纳 米科技股份有限公司2025年股票期权激励计划（草案）》（以下简称"本激励计划"、 "股权激励计划"）。 三、考核范围 本办法适用于参与公司本次股权激励计划的所有激励对象，为公司的董事、 核心技术人员、技术骨干及业务骨干。 四、考核机构 1、公司董事会薪酬与考核委员会负责领导和组织考核工作。 2、公司人力资源部门负责考核的实施和执行，保存考核结果，并对数据的 真实性和可靠性负责。 五、考核方法和考核内容 为保证股权激励计划的顺利实施，根据《公司法》《证券法》《上市公司股权 激励管理办法》（以下简称"《管理办法》"）等有关法律、法规、规范性文件以 及《公司章程》、公司股权激励计划的相 ...

证券简称：菲沃泰 证券代码：688371 江苏菲沃泰纳米科技股份有限公司 2025 年股票期权激励计划 （草案） 江苏菲沃泰纳米科技股份有限公司 二〇二五年四月 声 明 本公司及全体董事、监事保证本激励计划及其摘要不存在任何虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带 责任。 本公司所有激励对象承诺，公司因信息披露文件中有虚假记载、误导性陈述 或者重大遗漏，导致不符合授予权益或权益行使安排的，激励对象应当自相关信 息披露文件被确认存在虚假记载、误导性陈述或者重大遗漏后，将由本激励计划 所获得的全部利益返还公司。 1 特别提示 一、《江苏菲沃泰纳米科技股份有限公司 2025 年股票期权激励计划（草案）》 （以下简称"本激励计划"）由江苏菲沃泰纳米科技股份有限公司（以下简称"菲 沃泰"、"公司"或"本公司"）依据《中华人民共和国公司法》《中华人民共和国证 券法》、《上市公司股权激励管理办法》（以下简称"《管理办法》"）《上海证券交 易所科创板股票上市规则》《科创板上市公司自律监管指南第 4 号——股权激励 信息披露》及其他有关法律、法规、规范性文件，以及《公司章程》等有关规 ...

Financial Performance - The company's operating revenue for Q1 2025 was CNY 104,965,754.87, representing a 12.97% increase compared to CNY 92,913,492.03 in the same period last year[4]. - Net profit attributable to shareholders was CNY 6,313,627.91, up 20.04% from CNY 5,259,774.40 year-on-year[4]. - The net profit after deducting non-recurring gains and losses surged by 183.29%, reaching CNY 3,568,906.31 compared to CNY 1,259,788.90 in the previous year[4]. - Operating profit for Q1 2025 was ¥7,339,544.60, representing a 37.4% increase from ¥5,339,694.66 in Q1 2024[17]. - The company reported a net profit of RMB 4,183,507.50 for the period, recovering from a loss of RMB 2,130,120.41 in the previous period[14]. - The company’s total comprehensive income for Q1 2025 was ¥6,313,386.40, compared to ¥5,250,995.52 in Q1 2024[18]. Cash Flow and Assets - The net cash flow from operating activities was CNY 33,623,356.39, a significant recovery from a negative cash flow of CNY -13,797,072.47 in the same period last year[4]. - Cash flow from operating activities for Q1 2025 was ¥33,623,356.39, a significant recovery from a negative cash flow of -¥13,797,072.47 in Q1 2024[20]. - Cash and cash equivalents at the end of Q1 2025 totaled ¥223,563,268.29, down from ¥249,365,094.31 at the end of Q1 2024[21]. - The company's cash and cash equivalents increased to RMB 223,974,465.68 from RMB 182,005,082.42, representing a growth of approximately 23%[12]. - Total assets at the end of the reporting period were CNY 2,010,050,555.33, a decrease of 0.77% from CNY 2,025,574,271.48 at the end of the previous year[5]. - As of March 31, 2025, the company's total assets amounted to RMB 2,010,050,555.33, a decrease from RMB 2,025,574,271.48 as of December 31, 2024[12]. Liabilities and Equity - The total current liabilities decreased to RMB 99,591,869.86 from RMB 122,680,316.13, a reduction of about 19%[14]. - The company's total equity attributable to shareholders rose to RMB 1,907,785,955.18 from RMB 1,900,547,548.83, indicating a slight increase[14]. Research and Development - R&D investment totaled CNY 19,366,231.25, accounting for 18.45% of operating revenue, down from 22.86% in the previous year[5]. - Research and development expenses for Q1 2025 were ¥19,366,231.25, a decrease of 8.2% from ¥21,237,594.64 in Q1 2024[17]. Shareholder Information - The company had a total of 8,533 common shareholders at the end of the reporting period[8]. - Favored Tech Corporation Limited held 62.16% of the shares, with a total of 208,533,334 shares[9]. - The company repurchased a total of 4,658,312 shares, accounting for 1.3886% of the total share capital, with a total expenditure of RMB 50,202,577.62[11]. Non-Recurring Gains - The company reported non-recurring gains of CNY 2,744,721.60 after tax, primarily from government subsidies and other non-operating income[6].

北京市中伦律师事务所 关于江苏菲沃泰纳米科技股份有限公司 2025 年股票期权激励计划（草案）的 法律意见书 二〇二五年四月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 北京市中伦律师事务所 关于江苏菲沃泰纳米科技股份有限公司 2025 年股票期权激励计划（草案）的 法律意见书 致：江苏菲沃泰纳米科技股份有限公司 北京市中伦律师事务所（以下简称"本所"）接受江苏菲沃泰纳米科技股份 有限公司（以下简称"菲沃泰"或"公司"）委托，就公司 2025 年股票期权激励计 划（以下简称"激励计划"或"本激励计 ...

Group 1 - The core viewpoint of the news is that as of April 18, 2025, a total of 90 institutional investors hold shares in Favored Tech (688371.SH), with a combined holding of 246 million shares, representing 73.44% of the total share capital [1] - The top ten institutional investors collectively hold 72.45% of the shares, which is a decrease of 1.13 percentage points compared to the previous quarter [1] - The report highlights the significant presence of institutional investors in Favored Tech, indicating strong institutional interest in the company [1] Group 2 - In the public fund sector, one fund, Guotou Ruijin Specialized New Quantitative Stock Selection Mixed A, has reduced its holdings, showing a slight decline [2] - A total of 80 new public funds have disclosed their holdings this quarter, including notable funds such as Jianxin CSI 500 Index Enhanced A and Guotai Shanghai Composite ETF [2] - Three public funds have not disclosed their holdings this quarter, including Huashang Quantitative Progress Mixed and Huatai-PineBridge Quality Selection Mixed A [2]

Core Viewpoint - The company focuses on the research and development of nanomaterials technology, specifically high-performance multifunctional nanofilms, and aims to provide customized coating solutions and equipment to meet diverse customer needs [3][14][29]. Company Overview - The company is engaged in the research and development of nanomaterials technology, primarily producing high-performance multifunctional nanofilms and providing corresponding coating services [3][14]. - The company has developed various models of nanofilm coating equipment, which have been mass-produced and are used for preparing nanofilms [12][14]. Business Model - The company adopts an "order-based production" model for nanofilm preparation, utilizing both external and centralized production methods to meet customer demands [24][25]. - The company’s revenue is generated through customized nanofilm products and coating services, as well as the sale of nanofilm coating equipment [14]. Industry Situation - The new materials industry, including nanomaterials, is a strategic emerging industry in China, with significant government support and a clear development roadmap [29][30]. - The global market for nanofilms is projected to grow from approximately $14.18 billion in 2023 to over $66.35 billion by 2032, with a compound annual growth rate (CAGR) of 18.7% [32][33]. Technological Advantages - The company utilizes PECVD (Plasma-Enhanced Chemical Vapor Deposition) technology, which integrates various advanced techniques to produce high-quality nanofilms, providing a competitive edge in the market [35][36]. - The company has developed a new generation of equipment that combines PECVD and CVD processes, enhancing the stability and performance of the produced films [13][14]. Market Applications - The company’s nanofilms are widely used in consumer electronics, automotive, medical devices, and other industries, addressing diverse protective needs such as waterproofing, corrosion resistance, and surface modification [33][41][44]. - In the automotive sector, the demand for protective coatings is increasing due to the growing complexity of electronic components in electric vehicles [40][41]. Future Development Trends - The company is positioned to benefit from the increasing demand for nanofilms in various applications, particularly in consumer electronics and automotive industries, driven by technological advancements and market growth [39][40]. - The company aims to strengthen its research and development capabilities to maintain its competitive position and expand its market share in the nanomaterials industry [38].

Fundraising Overview - The company raised a total of RMB 1,554,914,370.06 through the issuance of 83,868,089 shares at a price of RMB 18.54 per share, with a net amount of RMB 1,436,386,093.00 after deducting issuance costs [1][2]. Fund Utilization - As of December 31, 2024, the company has utilized RMB 1,360,828,300.00 of the raised funds, with RMB 126,393,300.00 used in the 2024 fiscal year, leaving a balance of RMB 43,455,400.00 in the fundraising account [3][4]. - The company approved the use of surplus funds from completed projects to permanently supplement working capital, specifically transferring RMB 53,034,400.00 from the "Headquarters Park Project" [3][16]. Fund Management - The company established a management system for the use of raised funds, ensuring compliance with relevant laws and regulations, and implemented a dedicated account system for fund storage and management [4][6]. - The company has adhered to the three-party supervision agreement for the management of raised funds, ensuring strict approval processes for fund usage [6][19]. Cash Management - The company approved the use of up to RMB 350 million of temporarily idle raised funds for cash management, achieving an investment income of RMB 2,441,600.00 from these activities [10][11]. - As of December 31, 2024, there were no idle funds remaining from the cash management activities [12]. Financial Performance - The company reported a net profit of RMB 45,106,646.73 for the consolidated financial statements in 2024, while the parent company reported a net profit of RMB 15,285,102.17 [27]. - The parent company's accumulated undistributed profits were negative at RMB -59,237,162.29, leading to a proposal not to distribute cash dividends or issue new shares [26][27]. Board and Supervisory Actions - The board of directors approved the 2024 annual profit distribution plan, which includes no cash dividends or stock issuance, and this plan is subject to shareholder approval [28][61]. - The supervisory board confirmed that the company's fundraising and financial reports comply with relevant regulations and accurately reflect the company's financial status [102][104].

证券代码：688371 证券简称：菲沃泰 公告编号：2025-020 江苏菲沃泰纳米科技股份有限公司 第二届监事会第九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会议召开情况 江苏菲沃泰纳米科技股份有限公司（以下简称"公司"）第二届监事会第九次 会议于 2025 年 4 月 17 日在公司会议室以现场会议的方式召开。本次会议的通知 及会议资料已于 2025 年 4 月 7 日以专人送达的方式向全体监事送达。 本次会议应出席监事 3 人，实际出席监事 3 人。会议的召集和召开程序符合 《中华人民共和国公司法》（以下简称"《公司法》"）等有关法律法规、规范性文 件和《江苏菲沃泰纳米科技股份有限公司章程》（以下简称"《公司章程》"）的规 定，会议决议合法、有效。 二、监事会会议审议情况 经全体监事表决，形成决议如下： （一）审议通过了《关于公司 2024 年度监事会工作报告的议案》 公司监事会认为：2024 年度公司监事会本着维护公司以及股东利益的精神， 严格按照《公司法》等法律法规及《公司章程》的规 ...

第二届董事会第十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 江苏菲沃泰纳米科技股份有限公司 证券代码：688371 证券简称：菲沃泰 公告编号：2025-019 （一）江苏菲沃泰纳米科技股份有限公司（以下简称"公司"）第二届董事 会第十二次会议的通知和增加议案的通知已于 2025 年 4 月 7 日和 2025 年 4 月 17 日以电子邮件方式向全体董事、监事及高级管理人员送达，并取得全体董事 对本次会议按期召开的同意和认可。董事会会议通知包括会议的相关材料，同时 列明了会议的召开时间、地点、内容和方式。 （二）本次会议于 2025 年 4 月 17 日上午在公司会议室召开，采取现场会议 结合通讯方式进行表决。本次会议应出席董事九人，实际出席董事九人。会议由 董事长宗坚先生主持，公司全体监事及高级管理人员列席了本次会议。 （三）本次会议的召集和召开程序符合《中华人民共和国公司法》（以下简 称"《公司法》"）《上海证券交易所科创板股票上市规则》（以下简称"《上 市规则》"）等相 ...

证券代码：688371 证券简称：菲沃泰 公告编号：2025-009 江苏菲沃泰纳米科技股份有限公司 关于公司 2024 年年度利润分配方案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 ●江苏菲沃泰纳米科技股份有限公司（以下简称"公司"）2024 年末母公 司报表的累计未分配利润为负数，为保证公司的正常经营和持续发展，2024 年 度拟不派发现金红利，不送红股，不以资本公积转增股本。 ●公司 2024 年年度利润分配方案已经公司第二届董事会第十二次会议及第 二届监事会第九次会议审议通过，尚需提交公司 2024 年年度股东大会审议。 （一）公司 2024 年年度利润分配方案的制定充分考虑了公司的实际情况和 未来发展的资金需求，符合公司的实际经营情况，有利于公司的可持续发展，不 会对公司的正常经营活动产生影响； （二）本次利润分配方案尚需提交公司 2024 年年度股东大会审议通过。 根据立信会计师事务所（特殊普通合伙）出具的《审计报告及财务报表》（信 会师报字[2025]第 ZA11158 号），公司合 ...